• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后,年龄、肌酐和射血分数评分对非梗死相关慢性完全闭塞病变血运重建的预后价值:一项回顾性研究

Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: A retrospective study.

作者信息

Deng Jie, Wang Xiaozeng, Shi Yana, Zhao Xin, Han Yaling

机构信息

Department of Cardiology, The General Hospital of Shenyang Military Region, Chinese People's Liberation Army, Shenyang, China.

Department of Cardiology, Second Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.

出版信息

J Interv Cardiol. 2018 Feb;31(1):33-40. doi: 10.1111/joic.12448. Epub 2017 Sep 20.

DOI:10.1111/joic.12448
PMID:28940388
Abstract

OBJECTIVE

It is not known if ACEF scores could evaluate the prognosis of recanalization of non-infarct-related coronary arteries (non-IRA) with chronic total occlusions (CTO) in patients who successfully underwent primary PCI. The objective of the current study was to assess the prognostic value of ACEF scores in acute ST-segment elevation myocardial infarction (STEMI) patients with non-IRA CTO after successful primary PCI.

METHODS

There were 2952 STEMI patients who underwent successful primary PCI from January 2006 to December 2014 in our hospital, among them 377 patients had a non-IRA CTO lesion. The patients were divided into successful CTO-PCI group (n = 221) and failed/non-attempted CTO-PCI group (n = 156). Patients were stratified based on the ACEF tertiles. Primary end points measured in the current study were major adverse cardiac events (MACE) defined as the composite of all-cause death, nonfatal myocardial infarction, ischemia-driven coronary revascularization and hospitalization for heart failure at 1 year.

RESULTS

The incidence of MACE, all-cause death and cardiac death were higher in the failed/non-attempted CTO-PCI group (P < 0.001). In the successful CTO-PCI group, the cumulative 1-year incidences of MACE and all-cause death were decreased compared to those in the failed/non-attempted CTO-PCI group (log-rank P < 0.001). The risk for MACE was reduced in the successful CTO-PCI group compared to the failed/non-attempted CTO-PCI group in patients with low and intermediate ACEF scores (log-rank P = 0.02).

CONCLUSIONS

Successfully staged CTO-PCI could gain advantageous clinical outcomes in those patients with low or intermediate ACEF scores.

摘要

目的

对于成功接受直接经皮冠状动脉介入治疗(PCI)的患者,急性冠状动脉事件频率(ACEF)评分能否评估慢性完全闭塞(CTO)的非梗死相关冠状动脉(非IRA)再通的预后尚不清楚。本研究的目的是评估ACEF评分在成功进行直接PCI后的急性ST段抬高型心肌梗死(STEMI)合并非IRA CTO患者中的预后价值。

方法

2006年1月至2014年12月在我院成功进行直接PCI的2952例STEMI患者中,377例患者存在非IRA CTO病变。将患者分为CTO-PCI成功组(n = 221)和CTO-PCI失败/未尝试组(n = 156)。根据ACEF三分位数对患者进行分层。本研究测量的主要终点是主要不良心脏事件(MACE),定义为1年时全因死亡、非致命性心肌梗死、缺血驱动的冠状动脉血运重建和因心力衰竭住院的复合事件。

结果

CTO-PCI失败/未尝试组的MACE、全因死亡和心源性死亡发生率更高(P < 0.001)。在CTO-PCI成功组中,与CTO-PCI失败/未尝试组相比,1年累积MACE和全因死亡发生率降低(对数秩P < 0.001)。在ACEF评分低和中等的患者中,CTO-PCI成功组的MACE风险低于CTO-PCI失败/未尝试组(对数秩P = 0.02)。

结论

成功分期的CTO-PCI在ACEF评分低或中等的患者中可获得有利的临床结局。

相似文献

1
Prognostic value of the age, creatinine, and ejection fraction score for non-infarct-related chronic total occlusion revascularization after primary percutaneous intervention in acute ST-elevation myocardial infarction patients: A retrospective study.急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后,年龄、肌酐和射血分数评分对非梗死相关慢性完全闭塞病变血运重建的预后价值:一项回顾性研究
J Interv Cardiol. 2018 Feb;31(1):33-40. doi: 10.1111/joic.12448. Epub 2017 Sep 20.
2
The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion.年龄、肌酐和射血分数用于对接受冠状动脉慢性完全闭塞经皮冠状动脉介入治疗的患者进行风险分层。
Am J Cardiol. 2014 Oct 15;114(8):1158-64. doi: 10.1016/j.amjcard.2014.07.034. Epub 2014 Jul 30.
3
Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.ST 段抬高型心肌梗死患者慢性完全闭塞再通的长期影响。
Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.
4
ACEF score adapted to ST-elevation myocardial infarction patients: The ACEF-STEMI score.适用于 ST 段抬高型心肌梗死患者的 ACEF 评分:ACEF-STEMI 评分。
Int J Cardiol. 2018 Aug 1;264:18-24. doi: 10.1016/j.ijcard.2018.04.017. Epub 2018 Apr 6.
5
The impact of successful revascularization of coronary chronic total occlusions on long-term clinical outcomes in patients with non-ST-segment elevation myocardial infarction.冠状动脉慢性完全闭塞病变成功血运重建对非ST段抬高型心肌梗死患者长期临床结局的影响。
J Interv Cardiol. 2018 Jun;31(3):302-309. doi: 10.1111/joic.12501. Epub 2018 Mar 1.
6
Impact of successful staged revascularization of a chronic total occlusion in the non-infarct-related artery on long-term outcome in patients with acute ST-segment elevation myocardial infarction.非梗死相关动脉慢性完全闭塞病变经皮冠状动脉介入治疗对急性 ST 段抬高型心肌梗死患者长期预后的影响。
Int J Cardiol. 2013 Apr 30;165(1):76-9. doi: 10.1016/j.ijcard.2011.07.074. Epub 2011 Aug 26.
7
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.经皮介入治疗 ST 段抬高型心肌梗死合并慢性完全闭塞病变患者:EXPLORE 试验。
J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.
8
Impact of chronic total occlusion in a non-infarct-related coronary artery on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in ST-elevation myocardial infarction.非梗死相关冠状动脉慢性完全闭塞对 ST 段抬高型心肌梗死患者心脏磁共振成像评估的心肌损伤及预后的影响。
Int J Cardiol. 2018 Aug 15;265:251-255. doi: 10.1016/j.ijcard.2018.03.042.
9
Impact of chronic total occlusion in a non-infarct-related coronary artery on contrast-associated nephropathy in acute ST-elevation myocardial infarction.非梗死相关冠状动脉慢性完全闭塞对急性ST段抬高型心肌梗死中对比剂相关肾病的影响。
Acta Cardiol. 2023 Feb;78(1):118-123. doi: 10.1080/00015385.2022.2085357. Epub 2022 Jun 9.
10
Collateral filling efficiency of comorbid chronic total occlusion segment on short-term mortality in ST-elevation myocardial infarction.ST段抬高型心肌梗死中共存慢性完全闭塞节段的侧支循环灌注效率对短期死亡率的影响
Int J Cardiol. 2017 Mar 1;230:346-352. doi: 10.1016/j.ijcard.2016.12.107. Epub 2016 Dec 21.

引用本文的文献

1
The role of chronic total occlusions in non-infarct-related arteries in acute coronary syndrome patients: a systematic review.急性冠状动脉综合征患者非梗死相关动脉中慢性完全闭塞的作用:系统评价。
Future Cardiol. 2024;20(10):581-590. doi: 10.1080/14796678.2024.2406651. Epub 2024 Oct 9.
2
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score.整合血小板反应性、年龄、肌酐和射血分数评分,预测慢性冠状动脉综合征患者经皮冠状动脉介入治疗后的临床结局:PR-ACEF 评分。
Heart Vessels. 2024 Dec;39(12):1009-1017. doi: 10.1007/s00380-024-02430-5. Epub 2024 Jun 24.
3
Prevalence and associated factors of mortality after percutaneous coronary intervention for adult patients with ST-elevation myocardial infarction: A systematic review and meta-analysis.
ST段抬高型心肌梗死成年患者经皮冠状动脉介入治疗后死亡率的患病率及相关因素:一项系统评价和荟萃分析
J Res Med Sci. 2023 Mar 16;28:17. doi: 10.4103/jrms.jrms_781_21. eCollection 2023.
4
Age-Bilirubin-International Normalized Ratio (INR)-Creatinine (ABIC) Score, a Potential Prognostic Model for Long-Term Mortality of CAD Patients After PCI.年龄-胆红素-国际标准化比值(INR)-肌酐(ABIC)评分,一种预测冠心病患者PCI术后长期死亡率的潜在模型
J Inflamm Res. 2023 Jan 26;16:333-341. doi: 10.2147/JIR.S394502. eCollection 2023.
5
A comparison of long-term clinical outcomes between percutaneous coronary intervention (PCI) and medical therapy in patients with chronic total occlusion in noninfarct-related artery after PCI of acute myocardial infarction.急性心肌梗死后经皮冠状动脉介入治疗(PCI)的非梗死相关动脉慢性完全闭塞患者中 PCI 与药物治疗的长期临床结局比较。
Clin Cardiol. 2022 Jan;45(1):136-144. doi: 10.1002/clc.23771. Epub 2022 Jan 6.
6
Does multivessel revascularization fit all patients with STEMI and multivessel coronary artery disease? A systematic review and meta-analysis.多支血管血运重建适用于所有ST段抬高型心肌梗死和多支冠状动脉疾病患者吗?一项系统评价和荟萃分析。
Int J Cardiol Heart Vasc. 2021 Jun 11;35:100813. doi: 10.1016/j.ijcha.2021.100813. eCollection 2021 Aug.
7
The 11-Year Prognostic Impact of Chronic Total Occlusion in the Noninfarct-Related Coronary Artery on Patients with Acute Myocardial Infarction.非梗死相关冠状动脉慢性完全闭塞对急性心肌梗死患者 11 年预后的影响。
J Interv Cardiol. 2021 Mar 17;2021:6646804. doi: 10.1155/2021/6646804. eCollection 2021.
8
The long-term impact of a chronic total occlusion in a non-infarct-related artery on acute ST-segment elevation myocardial infarction after primary coronary intervention.非梗死相关动脉慢性完全闭塞对经皮冠状动脉介入治疗后急性 ST 段抬高型心肌梗死的长期影响。
BMC Cardiovasc Disord. 2021 Jan 30;21(1):59. doi: 10.1186/s12872-021-01874-1.
9
Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction.慢性完全闭塞病变经皮冠状动脉介入治疗对急性及围手术期心肌梗死的预后影响
J Clin Med. 2021 Jan 12;10(2):258. doi: 10.3390/jcm10020258.
10
Diurnal Variation in Outcomes of Percutaneous Coronary Intervention.经皮冠状动脉介入治疗结果的昼夜变化
Cureus. 2020 Apr 15;12(4):e7677. doi: 10.7759/cureus.7677.